0001493152-24-013225.txt : 20240404 0001493152-24-013225.hdr.sgml : 20240404 20240404171810 ACCESSION NUMBER: 0001493152-24-013225 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240401 FILED AS OF DATE: 20240404 DATE AS OF CHANGE: 20240404 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bailey Gregory CENTRAL INDEX KEY: 0001329505 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38519 FILM NUMBER: 24823985 MAIL ADDRESS: STREET 1: 4 A CHESHAM STREET CITY: LONDON STATE: X0 ZIP: SW1X8DT ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Serina Therapeutics, Inc. CENTRAL INDEX KEY: 0001708599 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 821436829 STATE OF INCORPORATION: AL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 601 GENOME WAY STREET 2: SUITE 2001 CITY: HUNTSVILLE STATE: AL ZIP: 35806 BUSINESS PHONE: (256) 327-9630 MAIL ADDRESS: STREET 1: 601 GENOME WAY STREET 2: SUITE 2001 CITY: HUNTSVILLE STATE: AL ZIP: 35806 FORMER COMPANY: FORMER CONFORMED NAME: AgeX Therapeutics, Inc. DATE OF NAME CHANGE: 20170606 4 1 ownership.xml X0508 4 2024-04-01 0 0001708599 Serina Therapeutics, Inc. SER 0001329505 Bailey Gregory 601 GENOME WAY, SUITE 2001 HUNTSVILLE AL 35806 1 0 0 0 0 Stock Option (right to buy) 11.828 2024-04-01 4 A 0 40000 0 A 2034-04-01 Common Stock 40000 44691 D The stock options vest in three equal installments on April 1, 2025, April 1, 2026 and April 1, 2027, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Number of derivative securities determined after giving effect to a reverse split of the Issuer's common stock of 1-for-35.17. /s/ Gregory Bailey 2024-04-04